ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

ClinicalTrials.gov ID: NCT04171492

Public ClinicalTrials.gov record NCT04171492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules

Study identification

NCT ID
NCT04171492
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Biodesix, Inc.
Industry
Enrollment
2,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2020
Primary completion
Nov 30, 2025
Completion
Nov 30, 2026
Last update posted
Sep 18, 2025

2020 – 2026

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Colorado Aurora Colorado 80045
Massachusetts General Hospital Boston Connecticut 02114
Beth Israel Deaconess Boston Connecticut 02215
MedStar Washington D.C. District of Columbia 20010
Indiana University Indianapolis Indiana 46202
The Johns Hopkins University Baltimore Maryland 21205
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
The Washington University St Louis Missouri 63110
Mount Sinai Health System New York New York 10029
Northwell Health New York New York 11042
The University of North Carolina Chapel Hill North Carolina 27599
Duke University Durham North Carolina 27705
Southeastern Research Center Winston-Salem North Carolina 27103
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University Coulmbus Ohio 43210
The Oregon Clinic Portland Oregon 97220
Ralph H Johnson VA Medical Center Charleston South Carolina 29401
Medical University of South Carolina Charleston South Carolina 29425
Prisma Health Greenville South Carolina 29605
University of Texas Southwestern Dallas Texas 75390
University of Texas Medical Branch Galveston Texas 77555
Virginia Commonwealth University Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04171492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04171492 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →